ticlopidine has been researched along with Reperfusion Injury in 9 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
Reperfusion Injury: Adverse functional, metabolic, or structural changes in tissues that result from the restoration of blood flow to the tissue (REPERFUSION) following ISCHEMIA.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In this study, we aimed to assess the effects of clopidogrel, an antithrombotic agent, on experimental ischemia-reperfusion model in rats." | 7.73 | Protective effects of clopidogrel on oxidant damage in a rat model of acute ischemia. ( Akbas, MH; Berki, KT; Bulbul, S; Kanko, M; Maral, H; Omay, O; Ozden, M; Yavuz, S, 2005) |
| " In this study, we aimed to assess the effects of clopidogrel, an antithrombotic agent, on experimental ischemia-reperfusion model in rats." | 3.73 | Protective effects of clopidogrel on oxidant damage in a rat model of acute ischemia. ( Akbas, MH; Berki, KT; Bulbul, S; Kanko, M; Maral, H; Omay, O; Ozden, M; Yavuz, S, 2005) |
| "Here we found that renal ischemia reperfusion injury in mice leads to increased platelet activation in immediate proximity of necrotic cell casts." | 1.46 | Release of extracellular DNA influences renal ischemia reperfusion injury by platelet activation and formation of neutrophil extracellular traps. ( Dessing, MC; Emal, D; Florquin, S; Jansen, MP; Roelofs, JJ; Teske, GJ, 2017) |
| "Ischemia and reperfusion injury is a pathologic process with serious consequences, arising due to interruption of arterial blood flow." | 1.33 | Effect of clopidogrel on nitric oxide levels in an ischemia reperfusion model. ( Acil, C; Kanko, M; Maral, H; Ozden, M, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kwong, W | 1 |
| Parker, JD | 1 |
| Weisshaar, S | 1 |
| Litschauer, B | 1 |
| Eipeldauer, M | 1 |
| Hobl, EL | 1 |
| Wolzt, M | 1 |
| Amagase, K | 1 |
| Yoshida, Y | 1 |
| Hara, D | 1 |
| Murakami, T | 1 |
| Takeuchi, K | 1 |
| Silber, T | 1 |
| Ziemann, U | 1 |
| Ernemann, U | 1 |
| Bischof, F | 1 |
| Demirtas, S | 1 |
| Karahan, O | 1 |
| Yazıcı, S | 1 |
| Guclu, O | 1 |
| Calıskan, A | 1 |
| Tezcan, O | 1 |
| Kaplan, I | 1 |
| Yavuz, C | 1 |
| Jansen, MP | 1 |
| Emal, D | 1 |
| Teske, GJ | 1 |
| Dessing, MC | 1 |
| Florquin, S | 1 |
| Roelofs, JJ | 1 |
| Hu, H | 1 |
| Batteux, F | 1 |
| Chéreau, C | 1 |
| Kavian, N | 1 |
| Marut, W | 1 |
| Gobeaux, C | 1 |
| Borderie, D | 1 |
| Dinh-Xuan, AT | 1 |
| Weill, B | 1 |
| Nicco, C | 1 |
| Kanko, M | 2 |
| Maral, H | 2 |
| Akbas, MH | 1 |
| Ozden, M | 2 |
| Bulbul, S | 1 |
| Omay, O | 1 |
| Yavuz, S | 1 |
| Berki, KT | 1 |
| Acil, C | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized, Double - Blind, Placebo - Controlled Trial to Investigate the Effect of Dapagliflozin on Ischemia Reperfusion Induced Endothelial Dysfunction of the Forearm Vasculature in Healthy Male Subjects[NCT05217654] | Phase 1 | 32 participants (Anticipated) | Interventional | 2022-02-18 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for ticlopidine and Reperfusion Injury
| Article | Year |
|---|---|
The Effect of Clopidogrel on the Response to Ischemia Reperfusion.
Topics: Adolescent; Adult; Biomarkers; Chemokine CCL5; Clopidogrel; Endothelium, Vascular; Female; Healthy V | 2017 |
Ticagrelor mitigates ischaemia-reperfusion induced vascular endothelial dysfunction in healthy young males - a randomized, single-blinded study.
Topics: Adenosine; Administration, Oral; Adolescent; Adult; Austria; Blood Flow Velocity; Clopidogrel; Drug | 2017 |
7 other studies available for ticlopidine and Reperfusion Injury
| Article | Year |
|---|---|
Prophylactic effect of egualen sodium, a stable azulene derivative, on gastrointestinal damage induced by ischemia/reperfusion, double antiplatelet therapy and loxoprofen in rats.
Topics: Animals; Aspirin; Azulenes; Benzoquinones; Clopidogrel; Gastric Mucosa; Gastrointestinal Hemorrhage; | 2013 |
Analysis of periinterventional complications of intracranial angioplasty and stenting: a single center experience.
Topics: Aged; Angioplasty; Aspirin; Blood Vessel Prosthesis Implantation; Clopidogrel; Diabetes Complication | 2014 |
Investigation of possible prophylactic, renoprotective, and cardioprotective effects of thromboprophylactic drugs against ischemia-reperfusion injury.
Topics: Animals; Anticoagulants; Aryldialkylphosphatase; Aspirin; Cardiotonic Agents; Clopidogrel; Dipeptida | 2015 |
Release of extracellular DNA influences renal ischemia reperfusion injury by platelet activation and formation of neutrophil extracellular traps.
Topics: Animals; Blood Platelets; Cell Line; Clopidogrel; Disease Models, Animal; DNA; Epithelial Cells; Ext | 2017 |
Clopidogrel protects from cell apoptosis and oxidative damage in a mouse model of renal ischaemia-reperfusion injury.
Topics: Animals; Apoptosis; Clopidogrel; Disease Models, Animal; Fluorescent Antibody Technique; Immunoblott | 2011 |
Protective effects of clopidogrel on oxidant damage in a rat model of acute ischemia.
Topics: Animals; Clopidogrel; Disease Models, Animal; Glutathione; Ischemia; Male; Malondialdehyde; Oxidants | 2005 |
Effect of clopidogrel on nitric oxide levels in an ischemia reperfusion model.
Topics: Animals; Clopidogrel; Disease Models, Animal; Intubation, Gastrointestinal; Liver; Lung; Muscle, Ske | 2006 |